Clinical trial Recruiting at 4 sites Interventional Ages 7 to 17

SMART treatment for youth with complex trauma

Official title: A Randomized Controlled Evaluation of Sensory Motor Arousal Regulation Treatment (SMART) for Youth With Developmental Trauma and Self-regulation Difficulties

Run by Vestre Viken Hospital Trust · NCT07200713 · Data updated 2026-11-12

This trial tests whether Sensory Motor Arousal Regulation Treatment (SMART) helps kids aged 7–17 with developmental trauma more than usual therapy.

Quick facts

Study typeInterventional
Ages7 Years to 17 Years
SexAll
Enrollment120 (estimated)
SponsorVestre Viken Hospital Trust
Academic / other
Locations4 sites (Asker, Akershus and 3 other locations)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedDecember 2028
Study endsJune 2029
Registry record updatedSeptember 9, 2026
Trial IDNCT07200713 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are youths aged 7–17 with developmental trauma history and measurable self-regulation difficulties, as determined by DTD-SI criteria.

Probably not a fit

Some participants may not experience meaningful improvement, particularly if trauma-related symptoms are driven by factors not addressed by SMART or TAU.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares SMART, a sensory-motor approach using specialized equipment to aid regulation, to treatment as usual for youths with developmental trauma and self-regulation difficulties. It aims to see if SMART improves emotional and bodily regulation, attention and behavior, and trauma-related symptoms at 6 and 12 months. The study also explores whether the quality of the therapeutic relationship influences outcomes and whether differences in response vary across patients. About 120 children and adolescents from four CAMH units in Norway are randomized to SMART or TAU, with a focus on real-world applicability and potential systemic adoption if effective.

Why it matters

Potential benefit: If successful, SMART could offer a more effective option for regulating emotions and reducing trauma symptoms in youth with complex trauma histories.

How similar studies have gone: This is a first randomized trial of SMART for youth; prior adult or preliminary work suggests potential benefit but formal pediatric evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

These are based on the Developmental Trauma Disorder Semistructured Interview (DTD-SI), which has four domains (A-D). Based on the DTD-SI, which is detailed below, inclusion requires:

* The presence of developmental trauma history (domain A)
* One symptom in each of the domains B-D
* At least four symptoms (of a maximum 15) in domains B-D considered together

Domains A to D above refers to the following:

* Domain A. Lifetime contemporaneous exposure to developmental trauma, defined as either (i) Interpersonal victimization: physical or sexual abuse or assault, domestic/intimate partner violence, bullying, harassment, exploitation, trafficking, hate crimes, or racial/ethnic/identity trauma, or (ii) Primary caregiving system attachment disruption: caregiver change or prolonged separation, gross neglect (physical, medical, emotional), psychological maltreatment (emotional abuse, emotional neglect, parental hostility or over-controlling), caregiver impairment due to mental illness or substance abuse, or chronic medical condition (by child or caregiver)
* Domain B. Affective and somatic dysregulation: (i) Emotion dysregulation, (ii) Somatic dysregulation, (iii) Impaired awareness or dissociation of emotions and body, (iv) Impaired capacity to describe emotions or bodily states
* Domain C. Attentional and behavioral dysregulation: (i) Threat-related rumination, (ii) Impaired capacity for self protection, (iii) Maladaptive self-soothing, (iv) Habitual or reactive self-harm, (v) Inability to initiate or sustain goal-directed behavior
* Domain D. Self and relational dysregulation: (i) Persistent extreme negative self-perception, (ii) attachment insecurity and disorganization, (iii) Extreme persistent distrust, defiance or lack of reciprocity in close relationships, (iv) Reactive physical or verbal aggression, (v) Psychological boundary deficits, (vi) Impaired capacity to regulate empathic arousal

Exclusion Criteria:

* Active psychosis
* Not fluent in Norwegian language
* Developmental challenges - IQ \< 70
* Has previously used SMART room

Where it's running

  • Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Asker
    Asker, Akershus, Norway
    Recruiting
  • Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Ringerike Ål
    Ål, Buskerud, Norway
    Recruiting
  • Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Drammen
    Drammen, Buskerud, Norway
    Recruiting
  • Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Kongsberg
    Kongsberg, Buskerud, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.